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Abstract 
 Background: A periapical lesion is an infection-induced inflammation around the 
apex of the tooth caused by bacterial invasion and ultimately results in the destruction of 
bone in the area. To date, the relationship between pathogens and the host immune 
system in the development of periapical lesions have been extensively investigated. 
However, a detailed understanding of the host factors that determine successful periapical 
wound healing is currently lacking. The long-term goal of the present study is to identify 
the molecular network that regulates wound healing and tissue regeneration in 
dentoalveolar infections in order to develop rational therapeutic approaches. Although a 
rodent model of periapical lesion was well established in Forsyth, adequate models for 
periapical wound healing are currently unavailable. Since the nature of apical 
periodontitis is infection-induced inflammation, the aim of this study was to 
systematically examine the effect of azithromycin treatment compared to ampicillin as a 
wound-healing treatment approach in mouse periapical lesions. Azithromycin is a 
macrolide antibiotic that specifically accumulates in macrophages exhibiting an anti-
inflammatory effect via alteration of macrophage phenotype from pro-inflammatory M1 
to anti-inflammatory M2 macrophages.  
  
 Material and Methods: Dental pulps of mandibular first molars in C57BL/6J 
mice (6 weeks of age) were surgically exposed and inoculated with a cocktail of common 
human endodontic pathogens, which are sensitive to employed antibiotics. Mice received 
daily doses of azithromycin (8 mg/kg), ampicillin (20 mg/kg) or phosphate-buffered 
saline (PBS) from day 10 to 20 post infection. No root canal treatments were provided. 
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Mandibles were isolated on days 10 (disease baseline) and 21. Right hemi mandibles 
were subjected to micro-computed tomography (µCT) to determine the extent of 
periapical bone loss and subsequent histological and immunohistochemistry analysis. 
Left hemi mandibles were used for RNA extraction for gene expression analysis through 
quantitative RT-PCR. Moreover, primary peritoneal macrophages stimulated with LPS 
and treated with either azithromycin or ampicillin were evaluated for pro-inflammatory 
cytokines expression (using ELISA) and nitric oxide production (iNOS assay). The effect 
of azithromycin in the level of NF-kB gene expression was assessed through luciferase 
reporter assay using Luciferase Stable RAW 264.7 cells. 
 
 Results: The µCT results indicated that azithromycin treatment suppressed the 
extent of periapical bone loss compared to PBS treatment with a significant difference 
(p<0.05) in the average size of periapical lesions. In addition, the extent of bone loss on 
Day 21 in azithromycin group was significantly “recovered” compared with the baseline 
disease group (p<0.05). In histological observations, azithromycin-treated animals 
showed less neutrophil infiltration and a polarization of M2 macrophages in periapical 
lesions, while PBS treatment resulted in moderate neutrophil infiltration and an M1/M2-
mixed macrophage profile. mRNA expression of pro-inflammatory cytokine IL-6 and 
chemokine CXCL2, as well as colony stimulating factor 2 (CSF2) had a significant down 
regulation in the  azithromycin group when compared to baseline disease (p<0.05). Up 
regulation of IL-4-mRNA was also observed. In vitro experiments confirmed the down 
regulation of IL-1# and IL-1$ (p>0.05) and nitric oxide production (p<0.05) in LPS 
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stimulated peritoneal macrophages treated with azithromycin. Finally, the luciferase 
activity was decreased when cells were stimulated with azithromycin 50uM.  
 
Conclusions: These results taken together suggest that the suppression of periapical bone 
loss by azithromycin appears to be dependent on its immunomodulatory properties. This 
report is the first finding on pro-resolving M2 macrophage polarization during periapical 
wound healing. This research can shed light to the development of a mouse model of 
periapical wound healing. In addition, this dual role of azithromycin, microbicidal and 
anti-inflammatory effects, could pose as a great adjuvant on the root canal therapy being 
highly translational. 
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Introduction 
 Endodontic infection is the infection of the root canal system and is the primary 
etiologic agent for periradicular inflammatory diseases (1, 2). A healthy root canal system 
is by nature an aseptic environment (3). The pathological process starts when the dental 
pulp becomes necrotic, either by caries, trauma or iatrogenic clinical procedures, and then 
infected by microorganisms that are usually inhabitants of the normal oral cavity flora 
(4). The environmental conditions in the necrotic root canal allow microbial colonization 
and multiplication, mainly by obligate anaerobic bacteria (5, 6). It is well established that 
the microorganisms and their by-products play a critical role on the development of 
pulpal and periradicular pathosis and their harmful effects have been the object of many 
studies over the years (1, 7). The host immune response to the root canal infection 
activates both innate and adaptive immune systems resulting in inflammation of 
periapical tissues and consequent bone destruction in the area known as apical 
periodontitis (8). 
 Macrophages are cells of the innate immune system which main role is to 
eliminate invading bacteria by phagocytosis and modulate adaptive immune responses by 
antigen presentation (9). Recent studies have shown the existence of different 
macrophage phenotypes, allowing us to better understand the properties and function of 
these cells. Diversity and plasticity are distinct features of macrophages (10). The early 
stages of the inflammatory process are typically associated with the M1 (pro-
inflammatory) macrophages, which will induce inflammation and tissue damage known 
as acute inflammation. The M2 (anti-inflammatory) subtype predominates during the 
subsequent resolution removing cell debris and promoting tissue remodeling. 
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 Azithromycin is a macrolide antibiotic shown to have immunomodulatory effects 
by accumulating in macrophages and shifting their polarization from a M1 to M2 
phenotype (11). 
  In the present research, we explored the effect of azithromycin in the healing of 
mouse periapical lesion by testing the hypothesis that failure of macrophage activation 
and polarization into M2 (anti-inflammatory) macrophage results in chronic 
inflammation and persistent apical periodontitis.   
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Review of Literature 
 
1. Endodontic infections and periapical lesions 
 A healthy root canal system is by nature an aseptic environment (3). Hence, upon 
exposure to microorganisms (usually inhabitants of the oral cavity) (4) due to caries, 
trauma or iatrogenic clinical procedures a pathological process starts leading to pulp 
necrosis. According to the American Association of Endodontists, more than 15 million 
root canal treatments are performed yearly in the US due to primary and secondary 
endodontic infections. Endodontic infection and necrotic pulp decrease the success and 
survival of endodontic therapy when compared to treatment of the inflamed dental pulp 
(12, 13). Even though endodontic outcome studies present great variability regarding the 
parameters used to assess success rates, like wide range of follow up, there is a consensus 
of opinion that presence of preoperative periapical lesion decreases the success rate of 
root canal treatment in about 10-15% (14, 15). In addition, patient presenting systemic 
diseases, like diabetes mellitus, have an even greater decrease in the success rate (16). 
Given the increasing prevalence of obesity and type 2 diabetes in the U.S. (>25 million 
and 8.3% of U.S. adults in 2011, respectively) (17), studies to elucidate the pathogenic 
mechanisms mediated by host factors in oral inflammation are essential so negative 
sequela in the endodontic treatment can be avoided in the future. Endodontic infections 
can cause signs and symptoms that range from mild discomfort to severe life threatening 
infections leading to serious systemic involvement such as cellulitis and angina (18, 19). 
There are profound consequences for patients and for the health care system due to the 
morbidity and cost of the management of non-healed cases. About 56% of all non-
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traumatic dental emergencies are in the form of periapical abscesses and toothaches (20, 
21). Finally, despite advances in the armamentarium for root canal treatment, like rotary 
files, ultrasonic irrigation and use of operating microscope, success have remained 
unchanged. 
 The microbial etiology of endodontic infections is well established (1, 2, 7) and 
its polymicrobial nature has been clearly demonstrated (1, 3). Once the root canal system 
has been contaminated, the microorganisms and their by-products play a critical role on 
the development of pulpal and periradicular pathosis.  
 A periapical lesion is an infection-induced inflammation view as an active 
confront between microbial factors and host defenses at the interface between infected 
radicular pulp and periodontal ligament. This encounter causes pathological changes at 
the tooth periapex in the form of tissue destruction and accumulation of inflammatory 
cells (8). Inflammatory mediators such as cytokines and chemokines are released in the 
area thus recruiting immune cells to participate in periapical defense (22). Cells of both 
the innate (neutrophils and monocyte/macrophages) and adaptive immune system (T 
cells, B cells and plasma cells,) play a role in the complex host response (23). The initial 
activation of the host response occurs through bacterial stimulation of toll-like receptors 
(TLRs) and nucleotide-binding oligomerization domain (NOD) receptors, both highly 
expressed in cells associated with periapical lesion including macrophages (24). As 
demonstrated by Hou et al, TLR4 deficient mice have reduced bone loss in the periapical 
area following endodontic infection due to decreased expression of inflammatory 
cytokines (25). Many studies have shown the presence of immunocompetent cells, such 
as T cells, plasma cells and macrophages in the periapical lesion (26, 27) and Stern et al 
! *&!
and Kawashima et al validated the predominance of macrophages in the area (28, 29). 
Periapical inflammatory infiltrates increase osteoclast numbers, and bone resorption is 
evident resulting in no reparative bone formation without treatment (30). Rapid bone 
destruction in the periradicular area can be attributed to proinflammatory cytokines such 
as IL-1$, IL-1#, receptor activator of nuclear factor kappa-B ligand (RANKL), TNF-#, 
IL-6 and IL-11 (23, 31).  
 A chronic infection develops as the necrotic tissue of the dental pulp is 
inaccessible to leukocytes and, therefore, represents a protected reservoir of bacteria (32). 
At this point, the host immune system is not fully competent to eliminate the invading 
pathogens and its by-products and a state of chronic inflammation is maintained.  
Modulation of the immune response is crucial for the achievement of complete wound 
healing in periapical lesion. The understanding of the role of M1 and M2 macrophages on 
those lesions and the development of new macrophage-centered therapeutic approaches is 
essential for the improvement of predictable periapical healing.  
 
2. Macrophage Polarization 
 Macrophages are important effector immune cells found in all tissues derived 
from the maturation of blood circulating monocytes. They were first described by Ilya 
Metchnikoff (33) in 1892 and remain to be a topic of intense research until today. 
Macrophages exert crucial functions in non-specific or innate immune system, which 
include phagocytosis of invading microbes and ingestion of host apoptotic cells. 
Additionally, they act as antigen presenting cells to activate adaptive immune responses 
(34). Routinely, macrophages serve as surveillance phagocytic entities responsible for the 
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removal of senescent cells and cellular debris involved in physiological activities. This 
role is described as homeostatic clearance and happens independently of other immune 
cells (35). Moreover, they will sense danger signals thru pattern recognition receptors 
(PRRs) and rapidly respond to microbial invasion and tissue damage (36).  
 Toll-like receptors (TLRs) and NOD-like receptors (NLRs) are important pattern 
recognition receptors found on macrophages which function is to recognize the conserved 
molecular configurations of microorganisms known as pathogen-associate molecular 
patterns (PAMPs) (37). This interaction is characterized by an inflammatory response 
where reaction oxygen species (ROS) and cytokines are produced. The powerful pro-
inflammatory reaction should be enough to contain the infection, however it can result in 
excessive tissue damage in some instances (36). Recruited monocytes have the ability to 
specialize into distinct tissue macrophages phenotypes in response to micro 
environmental stimulation. (38). This well-known characteristic so-called plasticity has 
long been recognized and is responsible for both pro and anti-inflammatory macrophage 
properties (39, 40). The macrophages will react differently to diverse stimulus and as a 
consequence, their activation response will give rise to different population of activated 
macrophages recognized as M1 or M2 (41). 
 The classically activated (M1) macrophages are activated in response to the 
cytokine interferon % (IFN %) alone or in conjunction with tumor-necrosis factor (TNF) or 
microbial products like lipopolysaccharide (LPS) (42). This activation mediates host 
defense against bacteria, viruses and protozoa and are also involved in antitumor 
immunity (35, 43). Natural killer (NK) cells of the innate immune system initially 
produce IFN % priming macrophages to secrete pro-inflammatory cytokines and release 
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oxygen and nitrogen radicals to enhance their phagocytic ability. To sustain the 
macrophage activation, T helper 1  (Th1) cells will subsequently produced IFN % 
providing a stable host defense (14, 20). M1 macrophages are characterized by their great 
capacity to produce interleukin-12 (IL-12) and interleukin-23 (IL-23) as well as CXCL9 
and CXCL10 chemokines (44), being referred as IL-12high and IL-10low(42).  
Furthermore, they exert a bacteriostatic effect with the shift in iron homeostasis by 
repressing ferroportin and inducing H ferritin favoring iron sequestration (22, 23). 
 Another population of activated macrophages has been elucidated and called 
alternatively activated or wound healing (M2) macrophages. IL-4 and/or IL-13, immune 
complexes and toll-like receptor, IL-1 receptor ligands or IL-10 can induce this 
polarization (45). These macrophage phenotypes possess a distinct function being 
primarily involved in the resolution of the acute phase of inflammation and tissue 
remodeling as well as with parasitic diseases. M2 macrophages are characterized by a 
limited production of pro-inflammatory cytokines and high secretion of anti-
inflammatory cytokines like IL-10, CCL18 and CCL22 and therefore described as IL-
10high and IL-12low. Abundant levels of mannose receptor CD206 and scavenging receptor 
CD163 also characterize them (20, 21, 24).  
 An additional key aspect of macrophage polarization is the predominant arginine 
metabolism pathway in the ongoing immune response. The immune cell arginine 
metabolism is essentially involved in cancer, inflammation, infections, fibrotic diseases, 
pregnancy, and immune regulation in general.  M1 macrophages carry the enzyme nitric 
oxide synthase (iNOS), which converts arginine to nitric oxide (NO) and citrulline known 
as the microbicidal and inflammatory pathway. NO can be further converted into reactive 
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nitrogen species that are fundamental defense against invading pathogens (46, 47). On the 
other hand, M2 macrophages express the enzyme arginase that transforms arginine to 
ornithine and urea. Ornithine is then converted into proline and polyamine, which favors 
proliferation as they are directly involved in collagen synthesis and cell proliferation 
respectively (47, 48).  
 It is fundamental to remember that M1/M2 polarization is a dynamic process and 
cells once polarized to pro-inflammatory phenotype can later be polarized to anti-
inflammatory phenotype and vice versa. These changes are fast and appear at the levels 
of gene expression, protein, metabolite, and microbicidal activity in response to changes 
in the cytokine environment as demonstrated by Davis et al (49). Evidence is clear 
regarding the potential damage caused by macrophages on the host tissue. Following 
exposure to toxicants, the number of activated macrophages is increased resulting in 
dysregulated release of pro and/or anti inflammatory mediators that, respectively, 
exacerbate acute tissue injury or promote the progress of chronic diseases such as fibrosis 
and cancer (50). Experimental models have shown that some agents, such gadolinium 
chloride and mannosylated clodronate liposomes, could block macrophages and prevent 
tissue injury.  
 
3. Selective M1/ M2 Macrophage depletion 
1. Gadolinium Chloride  
 Gadolinium chloride (GdCl3) is a rare earth metal shown to have the ability to 
block phagocytosis as verified by Roland et al in liver macrophages (Kupffer cells) (51). 
GdCl3 can be considered a macrophage toxicant, and is used to inhibit the mononuclear 
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phagocytic system (52). It has been demonstrated that gadolinium completely blocks 
stretch-activated cation channels (53), voltage-gated Ca2+ channels (54) and voltage-
gated Na+ and K+ channels. Due to Gd3+ ions and Ca2+ ions similarities it is believed 
that the biochemical effects induced by GdCl3 occur through interference with 
intracellular calcium-dependent processes and calcium entry into cells (55). According to 
Miron et al, administration of gadolinium chloride (GdCl3) in vivo is able to selectively 
deplete M1 macrophages. The inflammatory macrophages will phagocyte the GdCl3 
inducing their apoptosis via competitive inhibition of calcium and damage to plasma 
membranes. The same group also confirmed the selective depletion of M1 cells in vitro 
and was able to show that GdCl3 did not affect the M2 cell number (56). Similarly, 
Pendino et al used GdCI3 to suppress macrophage function and found that alveolar 
macrophages produced decreased quantities of nitric oxide and TNF-α, and expressed 
less inducible nitric oxide synthase (iNOS) (57). 
  
2. Mannosylated Clodronate Liposomes 
 Mannosylated clodronate liposomes (MCLs) can be used for selective depletion 
of M2 macrophages. Once liposomes are phagocytized by macrophages their 
phospholipid bilayers are disrupted by lysosomal phospholipases and clodronate is 
released intracellularly. Clodronate cannot cross the cell membrane and accumulates in 
the cell. At a certain intracellular concentration, irreversible damage causes the 
macrophage to be killed (58). Miron et al was able to selectively deplete M2 
macrophages in vivo and in vitro with administration of MCLs. They bind the mannose 
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receptor that is highly express in M2 macrophages, inducing apoptosis within 2-3 days 
via clodronate-mediated depletion of intracellular iron (56). 
 
4. Azithromycin 
 Azithromycin (AZM) is a semi-synthetic macrolide antibiotic, which presents 
broad-spectrum antibacterial activity (11). Macrolide antibiotics are drugs with a 
macrocyclic lactone ring containing from 12 to 16 atoms to which are attached one or 
more sugars (59). Erythromycin A was the first macrolide clinically used, being isolated 
in the early 1950s from cultures of Streptomyces (60). Macrolides reversibly bind to the 
23S rRNA and consequently, inhibit protein synthesis (61). Likewise, azithromycin 
inhibits bacterial protein synthesis by binding to 50S ribosomal subunit and interfering 
with elongation of peptide chain (62). AZM is effective against aerobic and anaerobic 
gram-negative and gram-positive bacteria, blocks quorum-sensing and inhibit formation 
of biofilm (63). It has been widely used for a great variety of infections, including upper 
and lower respiratory tract infections, and has been shown to have beneficial effects in 
chronic inflammatory disorders. The efficacy in these conditions has been attributed to 
immunomodulatory effects on innate and adaptive immune responses (11). Azithromycin 
has a large volume of distribution, high tissue concentration, extended half-life and is 
efficiently delivered to sites of infection (64). As reported by Lode et al, AZM half-life is 
approximately 70h (oral formulation) or 50h (intravenous), allowing infrequent dosing 
and greater patient compliance (65). 
 Azithromycin presents a very remarkable feature that is the accumulation into 
phagocytic cells. AZM is taken up by those cells, delivered to sites of inflammation and 
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then released during the process of phagocytosis to deliver locally high concentration of 
the drug (65). Due to this characteristic, AZM concentration in tissue have been reported 
to be up to 100 fold higher than in plasma (66) in several body tissues including 
periodontal pockets (67). The immunomodulatory effects of azithromycin include but are 
not limited to, down regulation in production of neutrophil chemokines (IL-8, CXCL1, 
MPO) (68). Moreover, a decrease in production of tumor necrosis factor-# (TNF-#) and 
granulocyte–macrophage colony stimulating factor (GM-CSF) in LPS-stimulated human 
macrophages has been reported (69). Additionally, AZM has been shown to shift the 
polarization of activated (M1) macrophages towards the alternative/ anti-inflammatory 
(M2) phenotype. 
 Several studies have reported the role of azithromycin on the polarization of 
macrophages to a M2 phenotype. Murphy et al investigated the in vitro effect of the drug 
in mouse macrophage cell line (J774) and concluded that AZM altered the macrophage 
phenotype. The authors have shown a decrease in production of pro-inflammatory 
cytokines and expression of M1 markers. On the other hand, M2 cell markers (mannose 
receptor and CD23) and anti-inflammatory cytokines were up regulated (70). 
Furthermore, they have confirmed the same finds in a murine model of lung infection 
(71). Another research group (72) also demonstrated an increase in expression of 
mannose receptor in alveolar macrophages from chronic obstructive pulmonary disease 
(COPD) patients in vitro. Reduced brain infiltration of inflammatory cells (neutrophils 
and macrophages) and induction of M2 polarization by AZM contributed to 
neuroprotection against ischemic stroke injury in mice (73).  
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 We believe that macrophage polarization towards anti-inflammatory/ pro-fibrotic 
(M2) phenotype is crucial for the wound healing of periapical lesions. To date, there are 
no reports correlating the use of azithromycin and macrophage polarization in the 
periradicular tissues.  This lack of evidence and gap in knowledge provided inspiration 
and was fundamental for the elaboration of this study.  
 
5. Wound Healing 
 It is essential that we understand the wound healing of periapical lesions. The 
process starts as soon as the chemomechanical cleaning and shaping of the root canal 
system is achieved. It is well known that inflammation is an essential part of the normal 
wound healing process, aiding on the clearance of invading microorganisms and restoring 
tissue homeostasis (74). Early stages of wound healing are characterized by abundant 
production of pro inflammatory cytokines by innate immune cells, with the objective of 
create an environment that protects the host from microbial infection (74). The process 
starts with the recruitment of neutrophils and macrophages to try to contain the infection. 
Later, the adaptive immune system is activated and cytokines and chemokines will 
promote macrophage shifting from M1 to M2 phenotype, the so-called late stage of 
wound healing.  In the late stages, macrophages undergo a phenotypic transition to a 
reparative stage, promoting clearance of the apoptotic cells, angiogenesis and tissue 
remodeling. These cells are said to be responsible for the switch from the inflammatory 
to the proliferative stages of wound healing (35, 74, 75).  When the root canal is 
effectively disinfected, the macrophage shifting occurs and wound healing takes place. 
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 Optimum wound healing and factors affecting the process is well discussed in 
cutaneous wounds, however, a detailed understanding of the host factors that determine 
successful periapical wound healing is currently lacking. Our long-term goal is to identify 
the molecular network that regulates wound healing and tissue regeneration in 
dentoalveolar infections in order to develop rational therapeutic approaches. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
! "%!
Specific Aim 
 
 The goal of the present study is to shed light on the understanding of endogenous 
regulatory mechanisms of inflammation and wound healing in periapical lesions. A 
rodent model of periapical lesion is well established, however a gap in knowledge 
remains regarding a rodent model of periapical wound healing after the establishment of 
periradicular infection. Evidence to date indicates that the shift of the phenotypic 
behavior of pro-inflammatory (M1) to anti-inflammatory (M2) macrophages is beneficial 
to modulate disease and promote tissue remodeling (76). Several drugs have been shown 
to promote this polarization, including azithromycin (56, 70). Besides its anti-microbial 
behavior, azithromycin shows anti-inflammatory properties. These properties combined 
make AZM a good approach for macrophage polarization in mice. Our rationale is that 
mice treated with azithromycin will have an increased pro-resolving M2 macrophage 
polarization and improved periapical wound healing. 
 
 
 
Hypothesis 
 We hypothesized that stimulation of M2 macrophage polarization will promote 
wound healing and induction of bone formation in mouse periapical lesions. 
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We will test our hypothesis by pursuing the following Specific Aims: 
 
Specific Aim 1: To identify the best approach for M1/M2 polarization. Gadolinium 
chloride (GdCl3) and mannosylated clodronate liposomes (MCLs) will be employ to 
deplete M1 and M2 macrophages respectively. Azithromycin will be used to look at the 
effect of macrophage polarization. 
 
Specific Aim 2: To determine the best treatment approach for M2 macrophages 
activation in periapical lesion. Azithromycin, Ampicillin and PBS treated mice will be 
compared to baseline diseased animals regarding the effect of treatment on the size of 
developed periapical lesions. M1/M2 macrophage profile will be analyzed by histology 
and immunohistochemistry. 
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Material and Methods 
1. In vivo: 
1. Animals: 
 Male and female C57BL/6J wild type (WT) mice of 6 weeks of age were 
purchased from The Jackson Laboratory (Bar Harbor, Maine, USA). The animals were 
maintained in a specific pathogen free (SPF) environment at The Forsyth Institute Animal 
Facility, housed in cages with filtered air circulation where the temperature was kept at 
70 +/- 5 degrees Fahrenheit with 50 +/- 20% relative humidity in accordance with the 
guidelines of the Institutional Animal Care and Use Committee. A 12-hour light/dark 
cycle was maintained and the animals were fed standard rodent chow and water at 
libitum. The Forsyth Institute Institutional Animal Care and Use Committee (IACUC) 
approved all experimental protocols before initiation of any experiment. 
 
2. Endodontic Pathogens: 
 Four common endodontic pathogens including Prevotella intermedia (ATCC 
25611), Streptococcus intermedius (ATCC 27335), Fusobacterium nucleatum (ATCC 
25586), and Peptostreptococcus micros (ATCC 33270) were selected as representatives 
of human endodontic microbiota not endogenous to mice (77). The pathogens were 
grown on 15 x 100 mm blood agar plates (5% Sheep Blood in Tryptic Soy Agar (TSA) 
Base; Hardy Diagnostics) under anaerobic conditions (85% N2, 10% H2, and 5% C02) 
for 48 hours. The cells were harvested and suspended in prereduced anaerobically 
sterilized Ringer’s solution (PRAS) (Anaerobe system-Morgan Hill, CA). The final 
concentration of each organism was determined spectrophotometrically, and the four 
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species of microorganism were mixed to yield a concentration of 1010 cells of each 
species/ml, resulting in a total of 4x1010 in 2% of methylcellulose (Parchem 
Methylcellulose, A4M Food Grade) (31). 
 
3. Induction of Periapical Lesion: 
 Periapical lesions were induced in both mesial and distal roots of mandibular first 
molars by surgical pulp exposure with exception of non-exposed/non-infected negative 
control mice: n=20 for preliminary study (macrophage depletion) and n=55 for 
azithromycin study. Mice were anesthetized with 62.5 mg/kg ketamine HCl and 12.5 
mg/kg xylazine in sterile phosphate-buffered saline (PBS) by intraperitoneal (I.P.) 
injection, using 26G needles (5/8 inch). Animals were placed on a jaw retractor board and 
right and left mandibular first molar pulps were exposed using a sterile dental round bur 
size & (SS White) mounted in a variable speed electric handpiece (Endo DTC® 
Endodontic Motor; Aseptico, Woodinville, WA) under a surgical microscope (model 
MC-M92; Seiler, St. Louis. MO). The exposure site was typically equivalent to 1.5-fold 
the diameter of the bur. The pulp chamber was opened until the entrances of both mesial 
and distal canals could be visualized with the help of a microsurgical mirror (Hu-Friedy, 
Chicago, IL) and probed with a #6 endodontic file (Dentsply). At the time of pulp 
exposure (day 0), animals were infected with 10 "l of the bacterial mixture inoculated 
directly into the exposed pulp by a 26 gauge needle. An endodontic file #6 was used to 
deliver the bacterial suspension into the mesial and distal root canals. The animals were 
monitored until recovering consciousness and placed back in their equivalent cages. 
Exposed pulps were left open during the 21 days of experimental protocol. 
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4. Macrophage Depletion (preliminary study): 
 On Day -1 relative to dental pulp exposure, mice received i.p. injection of either 
PBS or gadolinium chloride (GdCl3); or intravenous injection (retro orbital) of control 
blank liposome or mannosylated clodronate liposome (MCL). GdCl3 was used for 
selective depletion of pro-inflammatory M1 macrophages while MCL was used to 
selectively deplete anti-inflammatory M2 macrophages.  
 Filtered GdCl3 (Santa Cruz Biotechnology, Dallas,TX) in PBS (2.5 mg/mL; 100 
ul = 0.25 mg per mouse) was used for the injections. Sterile PBS was used as vehicle 
control. Since re-population of deleted cells starts from Day 3 post injection (55), GdCl3 
treatments was conducted on Days -1, 2, 5, 8, 11, 14, and 17 relative to pulpal exposure. 
 M2 macrophage depletion kit, consisting of MCL and control blank liposome was 
purchased from Encapsula Nano Sciences. 100 ul of m-Clodrosome® (Mannosylated 
Liposomal Clodronate) was used for each injection. The dose of clodronate disodium salt 
is 5 mg/mL, and 100 ul = 0.5 mg. 100 ul of m-Encapsome control liposomes was used as 
control (Mannosylated Clodrosome Kit). Intravenous injections (retro orbital vein plexus) 
were performed. MCL treatments were conducted on Days -1, 6, and 13 relative to pulpal 
infection according to a previous study conducting long-term macrophage depletion (78). 
 
5. Antibiotic treatment: 
 Azithromycin (500mg/vial) and ampicillin (1gram/vial) for injection were 
purchased from the Henry Schein animal health, Dublin, Ohio. On day 10 after pulp 
exposure, mice were randomly divided in 4 groups: 1) Disease baseline (Day 10 post 
exposure); n=10; 2) Ampicillin-treated; n=15; 3) Azithromycin-treated; n=15; and 4) 
! #+!
PBS-injected (vehicle/positive control); n=15. Daily injections of Ampicillin, 
Azithromycin and PBS were performed from day 10 to day 20 on the remaining groups. 
The route of injection was intraperitoneal (i.p.), and 26G needles (5/8 inch) were used. 
Treatment regimen was performed as follows: 0.2 mg azithromycin in 200 uL 
PBS/mouse/day was given once a day for initial two days, then the dose was reduced to 
0.1 mg/day in remainder of 8 days (based on 500 mg (initial dose/adult (60 kg)/day for 
pneumonia); 0.2 mg ampicillin in 200 uL PBS/mouse, once a day from day 10 to 20 
relative to the pulp exposure (based on 1000 mg/adult (60 kg)/day for such as urethritis); 
PBS (200uL) was injected as a vehicle control from day 10 to day 20 post pulp exposure. 
 Animals were sacrificed on Days 0 (non-infected control), Day 10 (Disease 
baseline) and Day 21 (experimental groups and positive control group) after the pulpal 
infection by carbon dioxide (CO2) asphyxiation following Forsyth standard operating 
procedure. Decapitation was conducted for sample isolation. 
 
6. Sample Isolation: 
 After death mice were decapitated, mandibles were isolated and hemi-sected. 
Right hemi mandibles were fixed in fresh 4% paraformaldehyde in PBS for at least 24 
hours and submitted to uCT analysis and subsequent histological analysis. Left hemi 
mandibles were immediately placed in liquid nitrogen and frozen at -80 degrees Celsius 
until RNA extraction. 
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7. Micro-computed tomography imaging (uCT): 
 The right hemi mandibles fixed in paraformaldehyde of all C57BL/6J wild type 
(WT) mice used in the study (experimental and control) were analyzed at Forsyth 
Institute by a compact fan-beam-type tomograph (µCT40 system, Scanco Medical AG, 
Bassersdorf, Switzerland) (79). The specimens were washed in PBS and placed in a 
cylindrical sample holder filled with distilled water. The samples were positioned in 
Styrofoam and aligned in the same manner in each tube for consistency. For each sample, 
approximately 300 micro-tomographic slices with an increment of 10 µm were acquired, 
covering the entire width of the mandible. Each sample took about 1 hour for the 
complete scanning. Data sets in DICOM format were re-sliced and analyzed using the 
Image J software (Wayne Rasband, National Institute of Health, Bethesda, MD). Pivotal 
sections including the crown and distal root of the mandibular first molar exhibiting a 
clear access opening and patent root canal apex were selected for quantitation. The 
periapical lesion size was measured using Adobe Photoshop CS6 (Adobe Systems, San 
Jose, CA). The area including the bone loss around the distal root of maxillary first molar 
was expressed as square millimeters (mm2) using a standardized template. 
 
8. Histological Analysis: 
 Fixed hemimandible samples used for mCT analysis were decalcified using 10% 
EDTA, dehydrated in ethanol, replaced with xylene and finally embedded in paraffin. 
Following serial sectioning at 6 "m thickness, every fifth specimen was mounted and 
stained with H&E following standard histological procedure. Following initial 
observation, sections containing the region of interest (patent root canal with localized 
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periapical lesion) were selected, mounted, and subjected to immunohistochemistry using 
the avidin-biotin peroxidase method for identification. Briefly, after deparaffinization 
using xylene and graded ethanol series, each section was subjected to endogenous 
peroxidase inhibitory treatment by 0.3% hydrogen peroxide with methanol (both Sigma-
Aldrich) for 30 minutes and protein blocking treatment used Protein Block (DAKO) for 
10 minutes. We employed the following 6 antibodies: 1) anti-mouse Mac2 antibody (total 
macrophage; 1:500, BioLegend); 2) anti-mouse Ly6G antibody (neutrophil; 1:1000, 
BioLegend); 3) anti-mouse iNOS antibody (M1 macrophage; 1:500, Abcam), 4) anti-
mouse Arg-1 antibody (M2 macrophage; 1:500, Abcam); 5) anti-mouse Osteocalcin 
(osteoblast; 1:500, Abcam); and 6) anti-mouse Cathepsin K (osteoclast; 1:500, Abcam). 
Antigen-antibody complexes were evidenced by the avidin-biotin peroxidase (ABC) 
method, using a commercially available kit DAB Peroxidase (HRP) Substrate Kit 
(DAKO). Finally, the sections were counterstained with hematoxylin, dehydrated in 
graded alcohol series, cleared in xylene and cover slipped with Eukitt (Sigma-Aldrich). 
The specificity of immune reactions was tested by omission of primary antibodies and/or 
substitution with isotype control. Cell enumeration and distribution analyses were carried 
out under light microscopy either at x100, x200 or x400 magnification. !
9. mRNA Extraction from Bone Block: 
 The left hemi mandibles were removed from -80°C, had their ends trimmed, 
transfer to an eppendorf tube containing 500 microliter (µl) of pre chilled RNAlater®-
ICE (Ambion® life technologies) and kept overnight in -20°C to inactivate RNase. On 
the next morning, soft tissues including gingiva, oral mucosa, muscles, and ligaments 
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were defleshed under a surgical microscope and tooth crown was dissected free of the 
samples and discarded. A bone block containing the periapical tissues surrounding the 
mesial and distal root apices of the mandibular first molar was carefully extracted and 
transfer to a Lysing Matrix A tubes (MP Biomedical) containing 2 ceramic spheres.  1 
milliliter (ml) of TRIzol® Reagent (Ambion® life technologies) was added to the tube 
and the contents were immediately disrupted using a high-speed homogenizer FastPrep®-
24 Instrument (MP Biomedical) for 20 seconds. Two cycles were performed. 
Subsequently, 200 microliter (µl) of chloroform was added to the tubes, incubated at 
room temperature for 3 minutes and centrifuged. The mixture was transferred to a Phase-
lock gel tube (5-Prime) and centrifuged for 5 minutes for phase separation. The separated 
aqueous phase solution containing total RNA was carefully transferred to a new tube. 
Isopropanol 99.5% was added in a 1:1 ratio and after centrifugation, a pellet of RNA was 
visible. The separated RNA was washed twice with 70% ethanol and air dried for 5 
minutes. RNA pellet was resuspended in 35 µl of RNase free water. RNA samples were 
then tested for purity and quantified using spectrophotometer Nanodrop 2000c (Thermo 
Scientific).  Samples showing 260/280 ratios of 1.7-2.0 were used for further qRT-PCR 
analysis. 
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Table 1. Gene selection for RT-PCR 
 
10. Quantitative Real Time Polymerase Chain Reaction (RT-PCR): 
 The synthesis of complimentary DNA (cDNA) was performed using iScript™ 
cDNA Synthesis Kit (Bio-Rad Laboratories) by adding 1 ug of purified total RNA, 4ul of %,! -./0-12! 034/2-56!7-,! 468!*ul! 59! 03:30;3! 2046;/0-124;3! -6! 4! 2524<! 59! *%ul solution. 
Quantitative Real Time Polymerase Chain Reaction (RT-PCR) was performed using 
Kapa Sybr® Fast qPCR Kit Optimized for LightCycler® 480 in a LightCycler® 480 
System (Roche). Pre-incubation cycle of 3 min at 95°C was performed. The temperatures 
and times for denaturation, annealing, and elongation were 95°C for 10 seconds, 58°C for 
20 seconds, and 72°C for 1 second, respectively, which were repeated for 50 cycles. 
Melting curve analysis was also performed with a single cycle of 95°C for 5 seconds; 
65°C for 60 seconds and 97°C prior to the final cooling at 40°C. The 2-ddCT was used for 
data analyses. The expression level of each gene was normalized to the corresponding 
GAPDH expression level. Azithromycin, ampicillin and PBS (Day 21) groups were 
compared to baseline disease group (day 10). Table 1 shows the genes chosen for the 
experiment. Likewise, AZM and AMP groups were compared to PBS. 
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2. In vitro: 
1. Macrophage Polarization 
a) Preparation of Mouse Blood Samples: 
 Blood was drawn from the retro orbital vein plexus of one mouse of each 
treatment group from the preliminary study as previously described: 1) Gadolinium 
Chloride; 2) PBS; 3) Mannosylated Clodronate liposomes; 4) Blank liposomes. 
Approximately 500 microliters (µl) of blood was obtained from each mouse using 
heparinized pipettes. Blood was diluted in 2 milliliter (2ml) of PBS and slowly 
transferred to a new tube containing 3ml of histopaque® 1083 (Sigma, Saint Louis, 
Missouri). Tubes were centrifuged at 1500 rpm for 30 min at room temperature. Red 
blood cells separated from white blood cells (WBC) and were deposited in the bottom of 
the tube. WBCs remained in the plasma/histopaque interface and were carefully transfer 
to a new tube. Cells were washed with PBS and centrifuged at 400xg for 5 min. Washing 
steps were repeated to remove any remaining histopaque® 1083 from the mononuclear 
cells. Cells were fixed with 4% paraformaldehyde (PFA) in PBS and kept in 4°C. 
 
b) Primary peritoneal macrophage isolation: 
 Non-infected C57BL/6J mice were euthanized in CO2 chamber, sprayed with 70% 
ethanol and placed on the dissection table. The abdominal skin was dissected and 5ml of 
cold Roswell Park Memorial Institute 1640 (RPMI-Gibco) medium was injected into the 
peritoneal cavity using a 26-gauge needle. The abdominal cavity was massaged to 
dislodge the macrophages and the entire body was shaken for 10 seconds to mix the 
medium well. Medium containing the macrophages were slowly drawn with an 18-gauge 
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needle beveled side down. The needle was left in place and another 5ml of RPMI was 
injected and aspirated. The cells were centrifuged, the supernatant was discarded and 
cells resuspended in 1ml of fresh RPMI medium supplemented with 10% fetal bovine 
serum (FBS). Nine ml of medium was added and cells were once again centrifuged. The 
washing step was repeated and cells were ready to be counted. The cells were seeded as 
follows: for ELISA assays = 1 x 105cells/ 100 µl/ well in 96 well plate; and 
 FACS assay = 3.5 x 106 cells/ 35mm plate. 
 
c) Primary peritoneal macrophage cell culture for FACs analysis: 
 Peritoneal macrophages (3.5 x 106 cells/35 mm plate) were pre-cultured in a 
humidifier incubator at 37°C containing 5% humidified CO2 for 6 hours to allow 
macrophages to adhere firmly to the dish. Experimental plates were pre-incubated for 1h 
with azithromycin or ampicillin and cells were stimulated as follows for 12 hours: 
 1.  Control: medium only 
 2.  LPS: for M1 activation (0.1ug/ml) 
 3.  M-CSF: for M2 activation (10ng/ml) 
 4.  LPS (0.1ug/ml) + Azithromycin (46ug/ml, 60uM) 
 5.  LPS (0.1ug/ml) + Ampicillin (100ug/ml) 
Cells were then harvested with 2.5mM EDTA in PBS, washed and fixed in 4% 
paraformaldehyde (PFA) in PBS and kept in 4°C. 
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d) Preparation of cells for flow cytometer (FACS) analysis:  
 Cells from mouse blood as well as cells from peritoneal macrophages were 
prepared for FACS analysis. Cells were added to FACS tubes in a concentration of 
1x106/ 100 µl. 2 µl of Fc receptor blocking antibody (TruStain fcX™ (anti-mouse 
CD16/32), BioLegend) was added for 5min prior to immunostaining. The following 
antibody stains (BioLegend, San Diego, CA) were added to the cells: a) FITC anti-mouse 
CD68 for total macrophages; b) APC anti-mouse CD80 for M1 macrophages; c) PE/Cy7 
anti-mouse CD206 for M2 macrophages. Unstained cells were used as control. Flow 
buffer consisting of 5% Fetal Bovine serum (FBS) plus 1mM EDTA in PBS was then 
added to each sample, shaked gently and centrifuged. Supernatant was collected, mix 
with fresh flow buffer and flow cytometry was performed using The BD FACSAria™ II 
cell sorter (BD Biosciences). Data were analyzed by FlowJo software (Tree Star, 
Ashland, OR).  
 
2. Stimulation of peritoneal macrophages for ELISA assay: 
 Peritoneal macrophages (106 cells/ well in 96-well plate) were pre-cultured with 
azithromycin (30uM) and ampicillin (100ug/ml) for 2 hours and then washed with RPMI 
supplemented with 10% FBS to remove non-adherent cells such as lymphocytes. 
Adherent cells were considered as macrophages and were stimulated with LPS (0.1ug/ml) 
for 20 hours in presence/absence of azithromycin (30uM) and ampicillin (100ug/ml). 
Non-stimulated/non-treated cells served as negative control, and cells stimulated with 
LPS alone served as positive control. Culture supernatants were collected 20 hours after 
incubation and subjected to Elisa assay to determine the level of IL-1α and IL-1β using 
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commercially available cytokine ELISA kits (DuoSets, R&D systems). The assays were 
conducted following the manufacture’s instructions. The concentration of each cytokine 
was calculated based on a standard curve constructed with specific recombinant cytokine 
provided in each kit. The results were measured in pg cytokine/ml of culture supernatant. 
 
3. Nitric Oxide production by peritoneal macrophages: 
 Peritoneal macrophages were harvested as described above and seeded in a 
concentration of 3.0 x 105 cell/ well in a 48-well plate. Cells were pre-incubated with 
azithromycin (46ug/ml, 60uM) and ampicillin (100ug/ml) for 1 hour and then stimulated 
with lipopolysaccharide (LPS, 0.1ug/ml). Cells were cultured in a humidifier incubator at 
37°C containing 5% humidified CO2 for 12 hours. Cell supernatants were subjected to 
Nitrate/Nitrite Colorimetric Assay (Cayman Chemical, Ann Arbor, MI) to measure the 
production of nitric oxide (NO) by activated macrophages. The results were measured 
and calculated from a standard curve and NO production was expressed in uM. !
4. NF-!B (nuclear factor kappa B) reporter assay: 
 The luciferase reporter assay is widely used as a tool to study gene expression at 
the transcriptional level. A commonly used reporter gene is the luciferase gene from the 
firefly Photinus pyralis (80). This gene encodes an enzyme that oxidizes D-luciferin, 
yielding a fluorescent product that can be quantified by a luminometer. To determine the 
level of NF-kB gene expression under proposed experimental conditions below, NF-kB 
Luciferase Stable RAW 264.7 cells (Applied Biological Materials, Canada) were 
employed. The cells were seeded in a 48-well plate (1.5 x 105 cell/ well), pre-incubated 
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with azithromycin in 3 different concentrations (12.5uM; 25uM and 50uM) for 1 hour 
and then stimulated with LPS (0.1ug/ml) for 12 hours. Medium alone was used as a 
baseline control and cells stimulated with LPS but no antibiotics served as positive 
control. The effect of antibiotics on LPS-stimulated luciferase activity was measured 
using Luciferase Assay System kit (Promega, Madison,WI) and absorbance read in 
Synergy HT (BioTek) reader. !
 
Statistical Analysis !
 In analyses of numerical data sets, the effect of one factor (e.g. treatment effect) 
on more than three groups (e.g. the extent of periapical lesions) was determined using 
One-way Analysis of Variance (ANOVA) and corrected by Dunnett’s Post Hoc test. 
Two-tailed Student’s t-test was used to compare the effect of one factor between two 
groups. In either analysis, the p value less than 0.05 was considered as statistically 
significant. !!
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Results: 
 Our proposed Specific Aim 1 was to identify the best approach for shifting of 
macrophage phenotype. The goal of this aim was to understand the feasibility of shifting 
the macrophage phenotype from the classically activated M1 macrophage to the 
alternatively activated M2 under either LPS or bacteria stimulation with the use of 
Gadolinium chloride (GdCl3), mannosylated clodronate liposomes (MCLs) and 
azithromycin. 
 
1. The effect of proposed treatments on M1 and M2 macrophages 
(FACS) 
 In order to evaluate selective depletion of each polarized macrophage population 
in mouse periapical lesions we chose to use Gadolinium (III) chloride (GdCl3) and 
mannosylated clodronate liposome (MCL) as they are shown to selectively deplete pro-
inflammatory (M1) and anti-inflammatory (M2) macrophages respectively (56). Pulp 
exposure was performed in both mandibular first molars and teeth were infected with 
endodontic pathogens. GdCl3 experimental group (n=5) received intra peritoneal 
injections (2.5mg/ml; 100 ul/ mouse) on days -1, 2, 5, 8, 11, 14, and 17 relative to pulpal 
infection PBS group (n=5) served as vehicle control receiving injections on the same 
schedule (100 ul of sterile PBS). In MCL groups, intravenous injections (5mg/ml;  
100 ul/mouse) of MCL experimental group (n=5) and blank liposome control group 
(n=5) were performed on days -1, 6, and 13 relative to pulpal infection. Blood samples 
were collected from all animals on day 21 and the population of M1 and M2 macrophage 
polarization was analyzed through flow cytometry. 
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a) Gadolinium (III) Chloride (GdCl3): 
 According to previous reports gadolinium chloride can inhibit phagocytosis and 
reduce the number of M1 resident macrophages (81). Miron et al successfully 
demonstrated the ability of pro-inflammatory M1 macrophage depletion by GdCl3 (56). 
 Although we expected a considerable decrease in M1 phenotype, our results 
showed (Fig.1: M1 depletion) that even though a decrease in M1 macrophage population 
could be observed in GdCl3 treated group that was no difference between GdCl3 and 
remaining experimental groups, including its PBS control group: 
• The ratio of M2/M1 cells was 1.98 in PBS group while it was 2.01 in GdCl3 
group; 
• GdCl3 treatment increased population of both M1 and M2 macrophages (x1.2 and 
x1.23, respectively); 
 No difference in M1 depletion between the PBS and GdCl3 groups suggesting 
that GdCl3 is not the best approach for our research. 
 
b) Mannosylated Clodronate Liposome (MCL): 
 Our expectation of selectively deplete M2 macrophages was founded on the 
reports from Miron et al. When M2 polarization occurs MCLs will bind to up regulated 
mannose receptor on those cells inducing apoptosis (56). 
 Selective depletion of M2 macrophages was effective in MCL treated mice in our 
experiment.  MCL treatment increased the ratio of M1/M2 (1.74) compared to that in 
blank liposome (BL) group (0.76). In addition, MCL treatment reduced M2 population 
(0.7-fold vs BL) whereas M1 population was increased by the MCL treatment (4-fold vs 
! $#!
BL). Unexpectedly blank liposome consistently reduced both M1 and M2 population 
compared to PBS control, suggesting a possibility that BL suppresses immune response 
vs PBS treatment (Fig. 1: M2 depletion).  
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                   M1 Depletion                                   M2 Depletion 
 
 
Figure 1. Flow cytometry analysis on macrophage polarization. Representative 
scatterplots of the 4 treatment groups showing M1 and M2 macrophage population. 
CD80 marker defines M1 cells represented on the top set of plots. CD 206 is used for M2 
cells shown on the bottom set of plots. CD86 marker shown on the X-axis represents total 
macrophage population. 
!!
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c) Azithromycin (AZM) vs. Ampicillin (AMP): 
 To compare the effect of azithromycin and ampicillin on the polarization of 
macrophages from a classical to an alternatively activated phenotype, we cultured 
primary peritoneal macrophages isolated from mice at 6 weeks of age. Cells were pre-
incubated with either azithromycin or ampicillin for 1 hour and then stimulated with LPS 
for 12 hours in the presence of antibiotics in the same condition. To serve as M1 
macrophages control, cells were stimulated with LPS alone. The cells stimulated with  
M-CSF served as M2 macrophages control. Non-stimulated cells served as a negative 
control. The cells were stained with specific macrophage markers and subsequently 
submitted to flow cytometry analysis. 
     The results obtained (Fig. 2) indicated that both azithromycin and ampicillin 
reduced the expression of M1 macrophages (CD80 marker) when compared with 
stimulation with LPS only. AMP suppressed M1 activation and the percentage of M1 
macrophages was similar to the control group. In contrast, AZM reduced M1 population 
(even under LPS stimulation) similar to the M-CSF treated cells. When looking at the M2 
marker (CD206) we noticed that azithromycin, but not ampicillin, up-regulated the 
expression of M2 macrophages.  In AMP group, the M2 population was similar to LPS 
group, while in AZM group, M2 population was higher in comparison to LPS but lower 
than M-CSF group (Fig.3).  
 In a series of experiments, only AZM treatment exhibited consistent phenotypic 
shift of the macrophage population to M2 macrophages. Thus, I mainly used AZM in 
subsequent experiments. 
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Figure 2: Flow cytometry analysis on M1 macrophage polarization in vitro: 
Scatterplots of stimulated peritoneal macrophages. Y-axis represents total macrophage 
cells stained with FITC CD68 marker. X-axis shows cells stained with APC CD80 (M1) 
marker. AZM presents a strong suppression of M1 polarized macrophages comparing to 
the other stimulants.  
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Figure 3: Flow cytometer analysis of M2 macrophage polarization in vitro: Plots 
showing FITC CD68 marker cells (total macrophages) on the Y-axis and PE-Cy7 CD206 
(M2 macrophage) marker cells on the X-axis. Up-regulation of M2 marker can be seen 
on AZM stimulated group. AMP had no affect on the CD206 (M2) marker cell 
expression. 
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 Ampicillin did not change macrophage population serving as a good control 
substance vs. azithromycin. 
 
 The Specific Aim 2 of this study predicts to determine the best treatment 
approach for M2 macrophages activation in periapical lesion. As described above, 
azithromycin was the treatment of choice for further experiments. 
 
 
2. The Effect of Azithromycin on the Extent of mouse periapical 
lesions 
 Evidence to date indicates that azithromycin can shift the phenotypic behavior of 
classically activated macrophages (M1) to alternatively activated (M2) (70). AZM 
contains a distinctive immunomudulatory effect that combined with its broad spectrum 
antimicrobial properties make it a perfect drug of choice for various infections. The drug 
has been used for the treatment of chronic inflammatory disorders (11) and its anti-
inflammatory property has been shown to improve lung function in cystic fibrosis 
patients (82, 83). The presence of macrophages in the periapical lesion is well established 
(81) but their role in the wound healing of those lesions still to be determined.  
 To assess the effect of azithromycin in the wound healing of mouse periapical 
lesions, we treated the animals with daily injections of AZM. Same scheduled of 
injection were given to ampicillin (AMP) and phosphate buffered saline (PBS) groups for 
comparison. Intra-peritoneal injections started 10 days after pulp exposure and root canal 
contamination with endodontic pathogens and were carried out until day 21 when mice 
were sacrificed. 
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a) Micro CT (uCT) Analysis 
  In order to measure the amount of periapical bone destruction, a non-invasive and 
rapid method was used (Fig. 4). Micro CT scanning was performed as described by Balto 
et al (79) on right hemi-mandibles of all groups (baseline disease, azithromycin, 
ampicillin and PBS).  The distal root of the mandibular first molar was selected for the 
bone loss measurement. The periapical lesion size was measured in mm2 using Adobe 
Photoshop CS5 (Fig. 5, 6 and 7).  
 As shown in (Fig. 5, 7) periapical bone destruction was induced after 10 days 
after pulp exposure. The extent of periapical lesion on day 10 was set as the disease 
baseline. On day 21, the PBS group (no treatment) had practically the same extent of 
bone resorption. Azithromycin treatment consistently suppressed the extent of periapical 
bone loss compared to PBS group with a significant difference (p<0.05) in the average 
size of periapical lesions. In addition, the extent of bone loss on Day 21 in azithromycin 
group was significantly recovered compared with the baseline group (p<0.05) suggesting 
that azithromycin is inducing bone formation on the area (Fig.6, 7). 
 
Figure 4: Representative uCT image of non-
exposed and non-infected mouse mandibular 
first molar with normal periradicular tissues. 
The lamina dura surrounding the distal root is 
intact and the periodontal ligament is uniform. 
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Figure 5: Representative "CT images of periapical lesions in Day 10 (baseline 
disease) and PBS (day 21) groups. (A) buccal-lingual view; (B) proximal view of distal 
root. Arrows demarcate periapical lesion. 
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Figure 6: Representative "CT images of periapical lesions in the azithromycin and 
ampicillin experimental groups. (A) buccal-lingual view; (B) proximal view of distal 
root. Arrows demarcate periapical lesion. Azithromycin treated animals presented 
decrease in lesion size compared to the other groups. 
AZM Day 21  AMP Day 21  
! %"!
!!
 
 
 
 
 
Figure 7: Extent of periapical lesion in mm2. Azithromycin treated animals had 
significant decrease in lesion size. Vertical bar: SD, *: p<0.05. 
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 In contrast to the results obtained with azithromycin, treatment with GdCl3 and 
MCL failed to modulate the extent of periapical lesion size. As seen in (Fig. 8), no 
significant difference could be observed between GdCL3 and PBS groups (p>0.05). 
Likewise, same findings were noticed in MCL and BL groups. 
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Figure 8: Quantification of bone loss in the periapical region (mm2). 
 A) Comparison between GdCl3 and PBS groups. B) Extent of periapical lesion in MCL 
and BL groups.  
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 We further pursue the investigation of potential mechanism of azithromycin-
mediated down regulation of inflammation and attenuated wound healing of periapical 
lesions through histology, immunohistochemistry and gene expression analysis of the 
mice samples.  
 
 
b) Histological Analysis 
 Periapical lesions are characterized by an infection-induced inflammation on the 
periradicular tissues. When the root canal system is exposed to bacteria and their by-
products, a non-specific inflammatory response occurs leading to host immunological 
responses on the area (84-86). Initial inflammatory responses consist of infiltration of 
polymorphonuclear leukocytes (PMNs) and macrophages and later, T-cells and B-cells 
can be observed. While we observed the reduction of periapical lesion size on the uCT 
analysis, we sought to conduct histological and immunohistochemistry evaluation to 
determine the type of inflammatory infiltrating cells as well as the macrophage phenotype 
present in the periradicular tissues of day 10 (baseline disease) and day 21 (treatment 
endpoint) treated animals. Hemi-mandibles were processed for standard histology and 
stained with H&E. Samples were subjected to immunohistochemistry using the follow 
antibodies:  1) anti-mouse Mac2 antibody (total macrophage); 2) anti-mouse Ly6G 
antibody (neutrophil); 3) anti-mouse iNOS antibody (a marker of M1 macrophage); 4) 
anti-mouse Arg-1 antibody (a marker of M2 macrophage); 5) anti-mouse Osteocalcin 
(osteoblast); and 6) anti-mouse Cathepsin K (osteoclast). 
 At day 10, we could observe extensive periapical lesions with prominent 
infiltration of inflammatory cells in the lesion of all specimens (Fig. 9) using H&E 
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staining. A mix population of neutrophils, classically (M1) and alternatively (M2) 
activated macrophages was noted when immunohistochemistry was performed. At day 
21, the same pattern of cell infiltration and localization was observed on the PBS 
(control) group with considerable amount of Ly6G+, Mac2+, iNOS+ and Arg-1+ cells 
overlapping (Fig.10). In contrast, both treatment groups, that are azithromycin and 
ampicillin, presented a decrease in neutrophils (Ly6G+) and pro-inflammatory (M1) 
macrophage (iNOS+) infiltration (Fig. 11, 12). Azithromycin treated group had a 
pronounced reduction in inflammatory cells and consequent decreased in periapical 
lesion size. Anti-inflammatory (M2) macrophages (Arg-1) were the predominant cell 
phenotype on the area. They were clearly separated from the other cell types and were 
located surrounding the margins of the lesion (Fig.11). Furthermore, osteocalcin + 
(osteoblast marker) cells were visualized lining the bone surface surrounding the 
periapical lesion in the azithromycin treated group, suggesting some bone regeneration 
(Fig. 13). Osteoblast could be visualized in certain ampicillin samples but were 
inconsistent compared to azithromycin group. No such cells were noted on the PBS 
(control), however, cathepsin K + (osteoclast marker) cells were present in PBS and 
ampicillin groups. 
 Cell enumeration analysis was not feasible due to cell clamping on the periapical 
area. Inflammatory cells presented as a mix population, especially on the control groups 
(day 10 and PBS), making it difficult to count and compare with azithromycin group. 
 The findings indicated that root canal infection is effective on the development of 
periapical lesions in mice at day 10. Additionally treatment with ampicillin and 
azithromycin are both effective on the reduction of periapical inflammation at day 21. 
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Even though ampicillin seems to reduce neutrophils and M1 macrophages infiltration 
surrounding the infected root, longer-term observation would be needed for the detection 
of bone regeneration. In contrast, animals treated with azithromycin demonstrated an 
enhanced periapical wound healing noticed by the recovered of bone on the area as well 
as the pattern and location of immune cells. These data suggest that azithromycin might 
be responsible for M2 polarization on the periapical lesion and helpful for accelerated 
wound healing.  
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Day 10: baseline disease 
 
 
 
 
Figure 9: Representative images of histological sections of Day 10 (baseline disease) 
group: A) H&E, B) Ly6G (neutrophils), C) Mac2 (total macrophages), D) iNOS (M1) 
and E) Arginase 1 (M2) immunostaining. Neutrophils and M1 macrophages are clearly 
the predominant cells on these samples. F) Overlying of infiltrating cells; green= Arg-1+; 
yellow= iNOS+; blue= LY6G+. No specific location can be visualized. Cells are 
overlapping inside the lesion. R: root; B alveolar bone; arrows demarcate periapical 
lesion. 
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Day 21: PBS group 
 
 
 
Figure 10: Representative images of histological sections of PBS group: A) H&E, B) 
Ly6G (neutrophils), C) Mac2 (total macrophages), D) iNOS (M1) and E) Arginase 1 
(M2) immunostaining. Inflammatory cells are the most abundant. F) Overlying of 
infiltrating cells; green= Arg-1+; yellow= iNOS+; blue= LY6G+. Overlapping of 
neutrophils and pro-inflammatory macrophages is evident. R: root; B alveolar bone; 
arrows demarcate periapical lesion. 
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Day 21: Azithromycin Group 
 
 
 
 
Figure 11: Representative images of histological sections of Azithromycin group:  
A) H&E, B) Ly6G (neutrophils), C) Mac2 (total macrophages), D) iNOS (M1) and  
E) Arginase 1 (M2) immunostaining. Inflammatory cells are much less abundant than 
PBS group. M2 (Arg-1+) cells are the predominant cells surrounding the lesion. F) 
Overlying of infiltrating cells; green= Arg-1+; yellow= iNOS+; blue= LY6G+. Distinct 
population of M2 macrophages can be observed. R: root; B alveolar bone; arrows 
demarcate periapical lesion. 
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Day 21: Ampicillin Group 
 
 
 
 
 
 
 
Figure 12: Representative images of histological sections of Ampicillin group:  
A) H&E, B) Ly6G (neutrophils), C) Mac2 (total macrophages), D) iNOS (M1) and  
E) Arginase 1 (M2) immunostaining. Great amount of neutrophils as well as M1 and M2 
macrophages. M2 (Arg-1+) cells surround the lesion. F) Overlying of infiltrating cells; 
green= Arg-1+; yellow= iNOS+; blue= LY6G+. No distinct population can be observed 
as it was on AZM group. R: root; B alveolar bone; arrows demarcate periapical lesion. 
 
 
! &*!
 
 
 
 
Figure 13: Representative immunohistochemistry of anti-mouse Osteocalcin in mice 
periradicular tissue: A) AZM group showing osteoblast cells lining the bone 
surrounding the periapical lesion. B) AMP group; C) PBS group. Both B and C lack 
osteocalcin+ cells. Some osteoblasts can be observed in the bone outside the periapical 
lesion. 
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c) Gene expression analysis: 
 In order to evaluate the expression level of several genes involved in the 
pathogenesis and wound healing of periapical lesions, we used the left hemi-mandibles of 
day 10 (baseline diseased), PBS, azithromycin and ampicillin groups. mRNA extraction 
was performed from the isolated bone block surrounding the root apices of mandibular 
first molar roots (more details are provided in the Material and Methods). Expression 
levels of genes involved in the inflammatory response, inflammasome, osteogenesis and 
wound healing as well as macrophage markers (refer to material and methods for full 
description of genes) were analyzed by Quantitative Real Time Polymerase Chain 
Reaction (RT-PCR) using GAPDH as internal control. The gene expression level of day 
21 treatment groups were compared to the infected mice sacrificed at day 10= baseline 
disease control (Table 2). 
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Table 2: Gene expression level of day 21 treatment groups. The gene expression 
levels were compared to day 10. Results are shown as fold up or down regulation 
comparing to baseline disease (day 10). Results in pink show fold change greater than 2. 
Results in blue demonstrate statistically significant fold change p<0.05. 
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 PBS (day 21 control group) presented a significant decreased (p<0.05) in the 
expression of pro-inflammatory cytokines IL-1α and IL-6 as well as CXCL2 chemokine 
and osteocalcin (Bglap) protein. Likewise, mRNA expression of IL-1β, IL-1rn, CCL5, 
IL-10 NLRP-1a, COL1a1 and SPP1 (osteopontin) were also down regulated (p>0.05) in a 
meaningful way when compared to baseline diseased mice (Table 3). IL-1α and IL-6 
have been implicated in bone resorption in the periapical lesion (87, 88) and the down 
regulation of those genes and the genes related to the inflammasome suggest that the 
periapical lesion at day 21 is no longer on the acute phase of inflammation.  
 
Table 3: List of genes on PBS group with fold change > 2 compared to baseline 
disease. Arrows mean down regulation. * Indicates statistical significant difference 
(p<0.05). 
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Figure 14: PBS gene expression data arranged in a 3D profile. Rows A and B: 
inflammatory response; C: macrophage markers; D: inflammasome; E: osteogenesis;  
F: wound healing. 
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 Azithromycin group showed a decrease in expression of pro-inflammatory 
cytokine IL-6 and chemokine CXCL2. Colony stimulating factor 2 (CSF2), together with 
the mentioned genes, had a significant down regulation in expression when compared to 
baseline disease (p<0.05). Fibroblast growth factor 2 (FGF2) was also down regulated 
(p>0.05). An interesting finding was the up regulation of the surface marker CD86 and 
the cytokine IL-4 (Table 4). CD86 is a co-stimulatory molecule that serves as ligand for 
activation of T-lymphocytes (89).  IL-4 has been reported to down regulate the 
expression of JKL*α! R)+S! 468! 75;2! -71502462<A! 25! 5F0! ;2F8AT! 25! 4/2-:423! 2I3!74/051I4E3!15<40-U42-56!25!46!>"!1I3652A13!R)*SM!
 
 
*+,!%&'()! C363! D3EF<42-56! G5<8!HI46E3!J69<4774250A!03;156;3! HOHK"! ! L"M"(!N!JKL&! L*M($!N!>4/051I4E3!740V30! H@(&! ! "M##!!W5F68!X34<-6E! H.G"! ! L*M&"!N!GCG"! L"M")!JKL$!! ! "M""!
 
Table 4. List of gene expression showing relevant fold change. CD86 and IL-4 were 
up regulated and FGF2 was down regulated (p>0.05). Statistical significant difference (*) 
could be observed on the down regulation of CXCL2, IL-6 and CSF2 (p<0.05). 
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Figure 15: AZM gene expression data arranged in a 3D profile. Rows A and B: 
inflammatory response; C: macrophage markers; D: inflammasome; E: osteogenesis;  
F: wound healing. Up regulation of CD86 and IL-4 is clearly noted. 
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 When examining the gene profile of ampicillin group, the genes that were down 
regulated with significance were similar to the PBS group, that is CXCL2, IL-6, CX3CR1 
(p<0.05), JKL*α! 468!BE<41! R1Y+M+%SM!A substantial fold increase was observed for the 
M1 macrophage marker CD80 when compared to baseline disease (table 5). 
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Table 5. List of gene expression showing relevant fold change in AMP group. Down 
regulation of HOHK"T! JKL&T! HO#HD*! (p>0.05) JKL*α! 468!BE<41! Z! 468!F1! 03EF<42-56! 59!H@(+!R1Y+M+%S!!403!;I5[6M (*) Indicates statistical significant difference. 
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Figure 16: AMP gene expression data arranged in a 3D profile. Rows A and B: 
inflammatory response; C: macrophage markers; D: inflammasome; E: osteogenesis;  
F: wound healing. Up regulation of CD80 is visibly noticeable. 
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 In order to evaluate whether the gene expression of the azithromycin treatment 
was corroborating to our immunohistochemistry findings on the wound healing and bone 
regeneration of the periapical lesions, we compared the data set of AZM and AMP 
groups to PBS group (day 21) (Table 6). 
Table 6: Gene expression level of AZM and AMP. The gene expression levels were 
compared to PBS group. Results are shown as fold up or down regulation. Results in pink 
show fold change greater than 2. Results in blue demonstrate statistically significant fold 
change p<0.05. 
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 Azithromycin group had an exponentially increase in the gene expression of the 
osteogenic genes Bglap, Col1a1 and Spp1. Expression of TGF$ mRNA showed a 
significant increase (p<0.05) when compared to PBS control. The gene expression of 
anti-inflammatory molecules IL-10 and IL-1Ra were up regulated, substantiating the 
hypothesis of M2 macrophage polarization by azithromycin. The gene expression of the  
ampicillin treated animals had  similar up regulation of  Bglap, Col1a1 and Spp1 
however, in far less extent than AZM group (Fig. 17). 
 
A) AZM gene profile                                       B) AMP gene profile 
 
Figure 17: 3D profile of gene expression of AZM and AMP treated mice compared 
to day 21 PBS control. Expression of osteogenic genes noted in dark blue on the E row.  
Fold difference of gene expression is noticeably up regulated in the AZM group. 
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 Expression patterns of RANKL mRNA (Fig.18) showed no difference amongst 
the groups. 
 
 
 
 
 
Figure 18: RANKL expression in periapical lesions. RT-PCR results showing the 
change in relative gene expression of RANKL mRNA to GAPDH (internal control) in all 
treatment groups. No significant difference was noted between the groups. 
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 Additionally, we have examined whether azithromycin modulate NF-kB 
activation and pro-inflammatory cytokine expression and nitric oxide production in vitro. 
The data obtained from the effect of AZM on the expression of pro-inflammatory 
cytokines IL-1# and IL-1$, as well as nitric oxide production were compared to AMP.  
 
 
3. NF-!B reporter assay 
 
 The luciferase reporter assay is broadly used as a tool to study gene expression at 
the transcriptional level. NF-!B (nuclear factor kappa B) is the key transcription factor 
for macrophage inflammatory responses (92). To evaluate the effect of azithromycin in 
the level of NF-kB gene expression NF-kB Luciferase Stable RAW 264.7 cells were 
used. The cells were pre-incubated with azithromycin for 1 hour, stimulated with LPS for 
12 hours. Then the cells were lysed and the relative luciferase activity was measured. The 
luciferase activity was decreased when cells were stimulated with AZM 50uM and AZM 
25uM while 12.5uM AZM failed down regulation of NF-!B (Fig. 19). This data suggests 
that azithromycin is capable of modulate NF-kB activation. 
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Figure 19: Luciferase activity upon stimulation with 3 different concentrations 
(12.5uM; 25uM and 50uM) of AZM * Indicates significant statistical difference  
p< 0.05 (vs control), †: p<0.05 (vs LPS). 
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4. Cytokine expression of stimulated peritoneal macrophages  
 
 In order to assess the effect of the antibiotics on the production of pro-
inflammatory cytokines IL-1# and IL-1$, peritoneal macrophages were stimulated with 
LPS in the presence/absence of azithromycin and ampicillin. Culture supernatants were 
measured by ELISA (pg cytokine/ml of culture supernatant). As shown in Fig. 20 
ampicillin showed a consistent up-regulation on the levels of IL-1# and IL-1$. The up- 
regulation of pro-inflammatory cytokines has been reported by \40<;2057 et al (93) 
corroborating our findings. Azithromycin stimulated cells had a slight decrease in the 
production level of IL-1# while IL-1$ expression but did not differ from the cells 
stimulated with LPS alone. 
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Figure 20: A) IL-1# and B) IL-1$ expression in response to antibiotics stimulants in 
vitro by peritoneal macrophages. Results are expressed as picograms of 
cytokine/milligram of supernatant. No statistical differences were observed. 
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5. Nitric Oxide production by stimulated peritoneal macrophages 
 iNOS, has been advocated as an important biomarker of inflammation, as its over-
expression leads to extreme production of nitric oxide, a free radical that plays an 
important role on the immune system (94). M1 but not M2 polarized macrophages exhibit 
up-regulation of iNOS (70). Azithromycin is known to shift the polarization to an 
alternatively activated (M2) phenotype and to test that veracity we stimulated pre-treated 
(azithromycin and ampicillin) peritoneal macrophages with LPS. The production of nitric 
oxide (NO) by activated macrophages was measured after 12 hours. Down-regulation of 
iNOS expression (≈ 76%) was clearly noticed in the azithromycin treated macrophages 
(p<0.05). Treatment with ampicillin decreased iNOS production but it was not statistical 
significant as presented in Fig.21. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21: iNOS expression when stimulated macrophages are exposed to AZM 
60uM and AMP 100ug/ml. AZM down -regulated expression of iNOS. * Indicates 
significant statistical difference (p<0.05). 
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Discussion 
 The pathophysiology of the pulp and periradicular tissues has been well studied 
and documented over the years. The pulp tissue is encased in a hard matter with almost 
no collateral circulation making it difficult to regenerate after injury. Injuries to the pulp 
can be caused by dental procedures like crown preparation, orthodontic treatment and 
bleaching. However the most damage is caused by caries that left untreated can lead to 
rapid pulp inflammation, degeneration and necrosis. Infection of the root canal will cause 
an immunoinflammatory reaction on the periapex and need for root canal treatment. 
 A periapical lesion is an infection-induced inflammation that surrounds the tooth 
root resulting in the formation of granulomatous tissue and the destruction of bone in the 
area. The disease initiates with bacterial infection into the root canal system and its 
progression is also affected by host factors. 
 Despite all the new technology and emerging endodontic armamentarium, the 
success rate of root canal treatment remains unchanged (14, 15). The presence of pre-
operative lesion and/or host immunosuppression decreases the prognosis even further. 
For example, diabetic patients have lower success rates after endodontic treatment, 
suggesting the importance of host factors on this disease (16, 95). However, periradicular 
wound healing is not completely understood thus a detailed investigation of the 
regulating molecular mechanisms is essential in order to develop rational therapeutic 
approaches that improve the healing of periapical lesions. 
 This study was based on the hypothesis that induction of M2 macrophage 
polarization will promote wound healing and induction of bone formation in mouse 
periapical lesions. Our primary focus was to determine the best method to induce that 
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polarization. We found that azithromycin is a practical choice to shift the macrophage 
polarization from a pro-inflammatory M1 to an anti-inflammatory M2 phenotype in vitro. 
Our in vivo studies showed that systemic treatment with azithromycin after pulp infection 
reduces the size of periapical lesion.  This report is the first finding on pro-resolving M2 
macrophage polarization during periapical wound healing. 
 
The effect of proposed treatments on M1 and M2 macrophages 
 Since alternatively activated (M2) macrophages have been characterized more 
than two decades ago (96), they have been shown to play crucial role in the resolution of 
the inflammatory responses and tissue remodeling in areas of injury. According to Sterns 
et al macrophages constitute the majority of the cells in periapical granulomas (28) and a 
shift of their polarization towards the anti-inflammatory (M2) phenotype could assist the 
wound healing in the periapical lesions. Therefore, we began by investigating the optimal 
treatment for macrophage polarization. We based our animal preliminary study in the 
findings that gadolinium chloride (GdCl3) and mannosylated clodronate liposome (MCL) 
selectively deplete M1 and M2 macrophage population respectively (56). C57BL/6J mice 
were injected with either GdCL3/PBS control or MCL/BL control and, at the end of the 
treatment schedule blood samples were subjected to flow cytometry (FACs) analysis to 
confirm macrophage polarization. This methodology was chosen because flow cytometry 
can rapidly analyze several characteristics of cells and give us qualitative and quantitative 
information (97).  GdCl3 was capable of depletion of M1 macrophages, however no 
difference could be observed in its control group (PBS) (Fig.1). We believe that 
incomplete depletion could be attributed to the route of administration of the solution. M1 
! (+!
depletion in rats using intravenous injections in the tail vein reported a repopulation of 
M1 macrophages as early as 3 days (98). The intra-peritoneal injection of GdCl3 might 
not have been effective enough to keep the M1 depletion in the same schedule as 
suggested by other studies (56, 98). Mannosylated clodronate liposome successfully 
depleted M2 macrophages as reported by Miron et al. However blank liposome (BL) was 
unpredictably more efficient on reducing both M1 and M2 macrophages (Fig. 1). This 
can be explained by the study from Rooijen et al that suggested that PBS or saline 
liposomes are not the correct control for liposome experiments. Healthy animals should 
be used as controls (99) once blank liposomes can block phagocytosis for a period of 
time (100). Since this point has not been concluded yet we decided to exclude this 
approach from or study. 
 On the other hand, azithromycin consistently shift the macrophage polarization to 
M2 phenotype in vitro as shown on Fig. 2 and Fig.3. These data coincide with a study by 
Murphy et al, in which they reported increased quantities of cells exhibiting M2 markers 
when a macrophage cell line was treated with azithromycin (70). Our data shows that 
primary peritoneal macrophages stimulated with azithromycin had an increase in CD206 
expression, a surface marker indicative of anti-inflammatory phenotype; and decreased in 
CD68, a surface marker for pro-inflammatory M1 macrophages. Zhang et al showed 
same results in vivo (101). Treatment with ampicillin had no effect on M2 polarization 
under LPS stimulation. 
 
 
 
! (*!
The Effect of Azithromycin on the Extent of mouse periapical lesions 
 We investigated the effect of azithromycin treatment on the extent of periapical 
lesions in mice. Pulp exposure and infection were performed in young adult mice (6 
weeks of age) and well-developed periapical lesions could be observed after 10 days 
(control group). Mice were then treated with azithromycin and ampicillin having PBS as 
control. Our results from uCT analysis showed that animals treated with azithromycin 
presented a decrease in size of periapical lesions exhibiting statistically significant 
difference when compared to PBS group (p<0.05) (Fig. 5, 6, 7). In addition, the lesions 
were reduced when compared to day 10 (p<0.05). As the lesion reached its peak at day 14 
according to Kawashima and Stashenko (101) and remain stable between days 15 and 30 
(26), we estimated that azithromycin stimulated bone recovery in the area at day 21. The 
decreased in inflammatory infiltrate in azithromycin group when analyzed by histology 
and immunohistochemistry might represent resolution of the inflammation and wound 
healing in the area. In similar way, Piancentini et al found reduction of airway neutrophil 
infiltration in asthmatic children after treatment with azithromycin (102). The anti-
inflammatory effect of AZM and macrolides in general seems to be associated with 
decrease of 105L-69<4774250A! /A25V-63; causing tI3! -6I-]-2-56! 59! 63F2051I-<!/I37524,-;!R*+#T!*+$SM!The greater amount of Arginase 1 + cells found surrounding the 
periapical lesions and lower quantity of iNOS+ in the AZM group are consistent with M2 
macrophages polarization (105, 106). On the other hand, generation of nitric oxide (NO) 
is a characteristic of pro-inflammatory immune cells such as neutrophils and M1 
macrophages (107). Even though nitric oxide production is necessary for bacteria killing, 
it triggers tissue destruction at the site of inflammation (108). Lin et al correlated NO to 
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osteoblast apoptosis in periapical lesion (109), while Gyurko et al demonstrated 
decreased amount of osteoclasts in the femur of iNOS KO compared to WT mice. The 
authors suggested that iNOS is an important signal for osteoclast differentiation (110)M In 
our study we found osteoblast cells lining the bone surface surrounding the periapical 
lesion in the azithromycin treated group. In contrast, osteoclast cells were lining the bone 
surface in the baseline disease and PBS groups. Our findings can be validated by the 
studies mentioned above as the iNOS + cells can be visualized in greater amount on the 
latter groups. The presence of considerable iNOS+ cells overlapping Ly6G+ and Arg-1+ 
and Mac2+ cells on the periradicular tissues of baseline disease group as well as on PBS 
and ampicillin groups suggest the development of a chronic inflammation on the 
periapex, know as periapical granuloma (26, 27). It is well reviewed in the literature that 
chronic periapical lesion contains a dense accumulation of polymorphonuclear (PMN) 
leukocytes, lined by granulomatous tissue containing lymphocytes, macrophages and 
plasma cells (8, 22, 86). It is important to remember that cells composing the chronic 
periapical granuloma (asymptomatic apical periodontitis; AAE terminology) are not 
static and can change their profile at any point causing a reagudization process.  
  The down regulation of pro-inflammatory genes IL-6, CXCL2 and colony 
stimulating factor 2 (CSF2) and increased expression of IL-4 in the azithromycin treated 
group when compared to baseline disease group reiterates our hypothesis that M2 
polarization can promote wound healing. Several authors have demonstrated production 
of IL-6 by the periradicular tissues (111, 112).  IL-6 mediates the acute phase of 
inflammation and induces bone resorption by recruiting osteoclasts to the site of 
inflammation (113, 114). Huang et al and Balto et al demonstrated controversial findings 
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where they found IL-6 to be protective against bone resorption in the periapical lesion of 
IL-6–/– mice (115, 116). CSF2 also known as granulocyte-macrophage colony-stimulating 
factor (GM-CSF) attracts pro-inflammatory macrophages to the site of inflammation, also 
confirmed in periapical lesion (113). Khan et al described a decrease in GM-CSF in LPS-
stimulated human macrophages treated with azithromycin (69). It has been reported that 
IL-4 reduces the levels of TNF-α, IL-1α and prostaglandin E2 (117), however Sasaki et 
al demonstrated that IL-4 did not suppress infection-stimulated bone resorption in mouse 
periapical lesion (31). PBS group showed a decrease in expression of pro-inflammatory 
genes suggesting a chronic and not acute phase of the inflammatory process in the area. 
Likewise, down regulation of pro-inflammatory genes were observed in ampicillin group, 
however the up regulation of CD80, a M1 macrophage marker suggests that wound 
healing is much slower than detected in azithromycin group. 
 A parallel comparison of gene expression was performed using the PBS group as 
control. Both AZM and AMP groups expressed up regulation of the osteogenic genes 
Bglap (osteocalcin), Col1a1 and Spp1 (osteopontin) with AZM group showing the 
greatest increase. Maeda et al found osteogenic markers, like osteocalcin and 
osteopontin, in human chronic apical lesions suggesting the potential contribution to 
osseous healing after root canal treatment (118). In our study, the osteogenic markers 
were increased without endodontic treatment proposing the role of azithromycin in the 
wound healing. Additionally, OPN-deficient mice had significantly increased in bone loss 
after pulp exposure and infection (119). The up-regulation of IL-10 expression reiterates 
the findings by Sasaki et al that demonstrated the role of IL-10 in infection-stimulated 
inflammatory responses suppression, including bone resorption (31). RANKL has been 
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recognized to have an critical role in osteoclastogenesis and it was showed to decrease 
after day 14 of pulp exposure in rats (120). Our results did not show this decrease. Day 
21 groups had about the same level of RANKL mRNA gene expression when compared 
to day 10 (baseline disease). 
 
 NF-!B reporter assay 
 NF-!B (nuclear factor kappa B) is a key mediator of inflammation and is 
activated by potent pro-inflammatory cytokines. The results of the NF-kB reporter assay 
showed that azithromycin down regulated NF-kB gene expression induced by LPS. 
Azithromycin was showed to suppress the activation of NF-kB and consequently the 
synthesis of pro-inflammatory cytokines (121, 122). 
   
Cytokine expression after azithromycin stimulation 
 Azithromycin has been showed to decrease the expression of the pro-
inflammatory cytokines IL-1α and IL-1β in vitro and in vivo (69, 123) being a suitable 
candidate for the treatment of chronic respiratory infections. Our results demonstrated a 
decrease in the expression of IL-1α and IL-1β in primary peritoneal macrophages 
stimulated with AZM. The cells stimulated with ampicillin showed an increase in the 
cytokines levels as described by Karlstrom et al (93). Neither treatment had a significant 
affect in the cytokine production when compared to cells stimulated with LPS only. 
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Nitric Oxide production by stimulated peritoneal macrophages 
 Down-regulation of iNOS expression was clearly observed in the azithromycin 
treated macrophages (p<0.05) whereas treatment with ampicillin decreased iNOS 
production in a non-significant manner.  Pro-inflammatory M1 but not anti-inflammatory 
M2 polarized macrophages exhibit up-regulation of iNOS according to Murphy et al 
(70). This finding confirms our experiments that azithromycin shifts the macrophage 
phenotype to an M2 phenotype. 
 These results taken together suggest that azithromycin is stimulating the wound 
healing of mice periapical lesion by facilitating macrophage polarization to an anti-
inflammatory M2 phenotype.  
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Conclusions 
 
• Azithromycin is a practical approach for shifting the macrophage polarization to 
an M2 macrophage phenotype in vitro and in vivo. 
 
• Azithromycin treatment led to immunomodulation of macrophages, an M2-
dominant profile from a mixed macrophage profile, in the mice periapical lesion. 
 
• Azithromycin-mediated M2 polarization in the periradicular tissues triggered 
subsequent wound healing via down regulation of NF-!B and subsequent 
production of pro-inflammatory cytokines and iNOS. 
 
• Azithromycin treatment also up-regulated osteogenic genes and might be 
involved in bone healing, resulting in reduction of periapical lesion size. 
 
• This study suggests the therapeutic potential of immunomodulation targeting M2 
macrophages for accelerated healing of apical periodontitis. The dual role of 
azithromycin, microbicidal and immunomodulatory effects, could pose as a great 
adjuvant on the root canal therapy being highly translational. 
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